Hosted on MSN2mon
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
FMIBlog5d
Global Research Antibodies Market Poised for Remarkable Growth, Projected to Reach USD 9.6 Billion by 2032 | FMI
Research Antibodies Market. The global research antibodies market is on a trajectory of significant expansion, driven by the ...
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...
Rapid Micro Biosystems Shares Rise in Premarket on New Distribution Agreement with Merck
Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...
Morningstar1mon
Merck Earnings: Gardasil Weighs on 2025 Growth, but Firm Still Undervalued
Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with overall 7% growth for the year. Shares fell more than 10% as Merck ...
TMCnet4d
Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors
Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...
Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...